243 related articles for article (PubMed ID: 28741789)
1. Screening of curcumin-derived isoxazole, pyrazoles, and pyrimidines for their anti-inflammatory, antinociceptive, and cyclooxygenase-2 inhibition.
Ahmed M; Qadir MA; Hameed A; Imran M; Muddassar M
Chem Biol Drug Des; 2018 Jan; 91(1):338-343. PubMed ID: 28741789
[TBL] [Abstract][Full Text] [Related]
2. Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies.
El-Shoukrofy MS; Abd El Razik HA; AboulWafa OM; Bayad AE; El-Ashmawy IM
Bioorg Chem; 2019 Apr; 85():541-557. PubMed ID: 30807897
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2018 Oct; 80():164-173. PubMed ID: 29929077
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anti-inflammatory, ulcerogenic and cyclooxygenase activities of indenopyrimidine derivatives.
Undare SS; Valekar NJ; Patravale AA; Jamale DK; Vibhute SS; Walekar LS; Kolekar GB; Deshmukh MB; Anbhule PV
Bioorg Med Chem Lett; 2016 Feb; 26(3):814-818. PubMed ID: 26764192
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH
Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents.
Tageldin GN; Ibrahim TM; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2019 Sep; 90():102844. PubMed ID: 31229797
[TBL] [Abstract][Full Text] [Related]
9. New substituted pyrazole derivatives targeting COXs as potential safe anti-inflammatory agents.
Abdellatif KR; El-Saadi MT; Elzayat SG; Amin NH
Future Med Chem; 2019 Aug; 11(15):1871-1882. PubMed ID: 31517535
[No Abstract] [Full Text] [Related]
10. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
11. Azomethines, isoxazole, N-substituted pyrazoles and pyrimidine containing curcumin derivatives: Urease inhibition and molecular modeling studies.
Ahmed M; Qadir MA; Hameed A; Arshad MN; Asiri AM; Muddassar M
Biochem Biophys Res Commun; 2017 Aug; 490(2):434-440. PubMed ID: 28623137
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents.
Mohammed KO; Nissan YM
Chem Biol Drug Des; 2014 Oct; 84(4):473-88. PubMed ID: 24720475
[TBL] [Abstract][Full Text] [Related]
13. Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents.
Abdelazeem AH; Abdelatef SA; El-Saadi MT; Omar HA; Khan SI; McCurdy CR; El-Moghazy SM
Eur J Pharm Sci; 2014 Oct; 62():197-211. PubMed ID: 24907682
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents.
Özadalı K; Özkanlı F; Jain S; Rao PP; Velázquez-Martínez CA
Bioorg Med Chem; 2012 May; 20(9):2912-22. PubMed ID: 22475926
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
Firke SD; Bari SB
Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656
[TBL] [Abstract][Full Text] [Related]
18. Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2.
Al-Suwaidan IA; Alanazi AM; El-Azab AS; Al-Obaid AM; ElTahir KE; Maarouf AR; Abu El-Enin MA; Abdel-Aziz AA
Bioorg Med Chem Lett; 2013 May; 23(9):2601-5. PubMed ID: 23528298
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential.
Said MF; Georgey HH; Mohammed ER
Eur J Med Chem; 2021 Nov; 224():113682. PubMed ID: 34245948
[TBL] [Abstract][Full Text] [Related]
20. Screening of chalcone analogs with anti-depressant, anti-inflammatory, analgesic, and COX-2-inhibiting effects.
Huang ZH; Yin LQ; Guan LP; Li ZH; Tan C
Bioorg Med Chem Lett; 2020 Jun; 30(11):127173. PubMed ID: 32278513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]